Literature DB >> 30939271

Role of Magnetic Resonance Imaging in Diagnosis of Motor Neuron Disease: Literature Review and Two Case Illustrations.

Khalid Sawalha1, Eduardo Gonzalez-Toledo2, Omar Hussein3.   

Abstract

Motor neuron diseases (MNDs) are a group of devastating neurologic disorders that cause specific damage to the motor neuron cells. The current diagnosis of MND is based on results of the clinical examination and neurophysiologic studies. The length of time of referral to a neuromuscular neurologist and the lack of validated diagnostic criteria can delay diagnosis. Although the role of imaging is currently most useful in excluding other conditions, several attempts to incorporate neuroimaging in the diagnosis of the disease and assessment of progression have shown promising results.We conducted a literature review via searches in PubMed and The Cochrane Database using multiple relevant terms to the topic. Two cases with a challenging diagnosis of MND are described, with a thorough discussion of how the diagnosis was suggested on the basis of magnetic resonance imaging evidence in each case. Advanced magnetic resonance imaging findings can be useful tools that add to the diagnostic criteria of MNDs, especially in cases where reaching a definitive diagnosis is difficult. Such findings might enable clinicians to reach an early diagnosis that can improve the patient's quality of life and prolong survival.

Entities:  

Mesh:

Year:  2019        PMID: 30939271      PMCID: PMC6380476          DOI: 10.7812/TPP/18-131

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  52 in total

1.  Diffusion tensor MRI assesses corticospinal tract damage in ALS.

Authors:  C M Ellis; A Simmons; D K Jones; J Bland; J M Dawson; M A Horsfield; S C Williams; P N Leigh
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

2.  Changes of resting state brain networks in amyotrophic lateral sclerosis.

Authors:  Bahram Mohammadi; Katja Kollewe; Amir Samii; Klaus Krampfl; Reinhard Dengler; Thomas F Münte
Journal:  Exp Neurol       Date:  2009-02-12       Impact factor: 5.330

3.  [The diagnosis of amyotrophic lateral sclerosis supported by motor evoked potential and brain MRI studies].

Authors:  K Matsunaga; M Iwamoto; S Tsuji; T Hashimoto; Y Murai
Journal:  Rinsho Shinkeigaku       Date:  1997-03

Review 4.  Motor neuron disease.

Authors:  P N Leigh; K Ray-Chaudhuri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

5.  EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.

Authors:  M Filippi; F Agosta; S Abrahams; F Fazekas; J Grosskreutz; S Kalra; J Kassubek; V Silani; M R Turner; J C Masdeu
Journal:  Eur J Neurol       Date:  2010-02-02       Impact factor: 6.089

Review 6.  Motor neuron disease: systematic reviews of treatment for ALS and SMA.

Authors:  Richard W Orrell
Journal:  Br Med Bull       Date:  2009-12-15       Impact factor: 4.291

7.  Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study.

Authors:  Esther Verstraete; Martijn P van den Heuvel; Jan H Veldink; Niels Blanken; René C Mandl; Hilleke E Hulshoff Pol; Leonard H van den Berg
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

Authors:  B J Traynor; M Alexander; B Corr; E Frost; O Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 9.  The current state-of-the-art of spinal cord imaging: methods.

Authors:  P W Stroman; C Wheeler-Kingshott; M Bacon; J M Schwab; R Bosma; J Brooks; D Cadotte; T Carlstedt; O Ciccarelli; J Cohen-Adad; A Curt; N Evangelou; M G Fehlings; M Filippi; B J Kelley; S Kollias; A Mackay; C A Porro; S Smith; S M Strittmatter; P Summers; I Tracey
Journal:  Neuroimage       Date:  2013-05-14       Impact factor: 6.556

Review 10.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

View more
  1 in total

1.  Description of combined ARHSP/JALS phenotype in some patients with SPG11 mutations.

Authors:  Marzieh Khani; Hosein Shamshiri; Farzad Fatehi; Mohammad Rohani; Bahram Haghi Ashtiani; Fahimeh Haji Akhoundi; Afagh Alavi; Hamidreza Moazzeni; Hanieh Taheri; Mina Tolou Ghani; Leila Javanparast; Seyyed Saleh Hashemi; Ramona Haji-Seyed-Javadi; Matineh Heidari; Shahriar Nafissi; Elahe Elahi
Journal:  Mol Genet Genomic Med       Date:  2020-05-08       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.